Ro 31-8959 proteinase inhibitor: Began a 40-center, U.S. Phase III trial in 1200 patients with advanced HIV who have had previous AZT therapy and have CD4 cell

Hoffmann-La Roche Inc., Nutley, N.J. Product: Ro 31-8959 proteinase inhibitor Indication: Slow progression of HIV Status: Began a 40-center, U.S. Phase III trial in 1200 patients with advanced HIV wh...